Wordt geladen...
Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?
Many recent studies have demonstrated the range of disorders in which monoclonal antibodies have a clinical role. The monoclonal antibody NA1/34, directed against a surface antigen present on lesional cells ('LCH cells'), has been found to localise in vivo to sites of disease. This review...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
1994
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2149709/ https://ncbi.nlm.nih.gov/pubmed/8075008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|